Leadership

Jill Gilmour, Ph.D.

VP and Chief Technology Officer
Human Vaccines Project

Educated at University of Edinburgh, Professor Jill Gilmour, Ph.D. has almost 30 years of translational immunology experience. Her research has focused HIV and Vaccine development, focused on the African epidemic and associated capacity building. Most recently she served as the Executive Director for Human Immunology at IAVI and was the founding member and Principal Investigator of the Human Immunology Laboratory (HIL) at Imperial College, London.She was also responsible for establishing and supporting IAVI’s Clinical Laboratory Program and staff internationally, overseeing research strategy, immune monitoring, data, quality, and scientific and laboratory capacity building to support HIV vaccine trials and epidemiology studies. Jill developed and co-lead large multi-center immunology and epidemiology studies in East and Southern Africa, and was a founder and Scientific Director for the VISTA Initiative (Vaccine Immunology Science and Technology for Africa), developing strategic partnerships to encourage collaboration, technology transfer and training opportunities with partners in Europe, the United States, Africa and India to understand immune mechanisms of HIV control, the nature of the transmitted virus and translate these into next generation vaccine designs and assays. This included developing an integrated data platform to ensure sample and data access and sharing.

Prof Gilmour has engaged with a broad spectrum of International Donors and Foundations, Biotechs and large Pharmaceutical companies and was the PI/co-investigator on a number of grants and awards to support reference testing, immune corelate analysis, and training for global consortia and vaccine initiatives across a range of diseases including HIV, TB, malaria, Ebola and other hemorrhagic fevers and emerging diseases. She participates in many international steering and working groups and maintains a Professor of Practice at Imperial College.

Prior to joining IAVI in 2001, Dr Gilmour’s research focused on the host immune system in HIV transmission notably in the African epidemic. She held a post-doctoral fellowship of the UK MRC AIDS directed program and was a Lecturer at Imperial College London and worked with MRC/UVRI Uganda Research Unit on AIDS to develop its cellular immunology laboratory, mentoring Ph.D. students and technical staff based in the United Kingdom and Uganda. She has co-authored more than 100 peer-reviewed scientific publications.

BACK TO TEAM